Reviews Oleptro


No reviews yet.

Oleptro Drug Description
OLEPTRO
(trazodone hydrochloride) Extended-Release Tablets

WARNING
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of Oleptro or any other antidepressant in a child,
adolescent, or young adult must balance this risk with the clinical need. Short-term
studies did not show an increase in the risk of suicidality with antidepressants
compared to placebo in adults beyond age 24; there was a reduction in risk with
antidepressants compared to placebo in adults aged 65 and older. Depression
and certain other psychiatric disorders are themselves associated with increases
in the risk of suicide. Patients of all ages who are started on antidepressant
therapy should be monitored appropriately and observed closely for clinical
worsening, suicidality, or unusual changes in behavior. Families and caregivers
should be advised of the need for close observation and communication with the
prescriber. Oleptro is not approved for use in pediatric patients [see WARNINGS
AND PRECAUTIONS and PATIENT
INFORMATION].

DRUG DESCRIPTION
Oleptro (trazodone hydrochloride) is a triazolopyridine. It is a white, odorless
crystalline powder which is freely soluble in water.
Chemical Name: 2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one
monohydrochloride
Structural Formula:








Molecular Formula: C19H22ClN5O•HCl
Molecular Weight: 408.32
Oleptro tablets containing 150 mg or 300 mg of trazodone hydrochloride are
designed to release their drug content over a 24-hour period and are intended
for once-a-day dosing.
Inactive Ingredients:
Hydroxypropyl distarch phosphate (Contramid®)
Hypromellose
Sodium stearyl fumarate
Colloidal silicon dioxide
Iron Oxide Yellow
Iron Oxide Red
Talc
Polyethylene Glycol 3350
Titanium Dioxide
Polyvinyl Alcohol
Black ink (food grade)
Last reviewed on RxList: 2/25/2010




Oleptro Drug Description
OLEPTRO
(trazodone hydrochloride) Extended-Release Tablets

WARNING
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of Oleptro or any other antidepressant in a child,
adolescent, or young adult must balance this risk with the clinical need. Short-term
studies did not show an increase in the risk of suicidality with antidepressants
compared to placebo in adults beyond age 24; there was a reduction in risk with
antidepressants compared to placebo in adults aged 65 and older. Depression
and certain other psychiatric disorders are themselves associated with increases
in the risk of suicide. Patients of all ages who are started on antidepressant
therapy should be monitored appropriately and observed closely for clinical
worsening, suicidality, or unusual changes in behavior. Families and caregivers
should be advised of the need for close observation and communication with the
prescriber. Oleptro is not approved for use in pediatric patients [see WARNINGS
AND PRECAUTIONS and PATIENT
INFORMATION].

DRUG DESCRIPTION
Oleptro (trazodone hydrochloride) is a triazolopyridine. It is a white, odorless
crystalline powder which is freely soluble in water.
Chemical Name: 2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one
monohydrochloride
Structural Formula:








Molecular Formula: C19H22ClN5O•HCl
Molecular Weight: 408.32
Oleptro tablets containing 150 mg or 300 mg of trazodone hydrochloride are
designed to release their drug content over a 24-hour period and are intended
for once-a-day dosing.
Inactive Ingredients:
Hydroxypropyl distarch phosphate (Contramid®)
Hypromellose
Sodium stearyl fumarate
Colloidal silicon dioxide
Iron Oxide Yellow
Iron Oxide Red
Talc
Polyethylene Glycol 3350
Titanium Dioxide
Polyvinyl Alcohol
Black ink (food grade)
Last reviewed on RxList: 2/25/2010




Oleptro Drug Description
OLEPTRO
(trazodone hydrochloride) Extended-Release Tablets

WARNING
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of Oleptro or any other antidepressant in a child,
adolescent, or young adult must balance this risk with the clinical need. Short-term
studies did not show an increase in the risk of suicidality with antidepressants
compared to placebo in adults beyond age 24; there was a reduction in risk with
antidepressants compared to placebo in adults aged 65 and older. Depression
and certain other psychiatric disorders are themselves associated with increases
in the risk of suicide. Patients of all ages who are started on antidepressant
therapy should be monitored appropriately and observed closely for clinical
worsening, suicidality, or unusual changes in behavior. Families and caregivers
should be advised of the need for close observation and communication with the
prescriber. Oleptro is not approved for use in pediatric patients [see WARNINGS
AND PRECAUTIONS and PATIENT
INFORMATION].

DRUG DESCRIPTION
Oleptro (trazodone hydrochloride) is a triazolopyridine. It is a white, odorless
crystalline powder which is freely soluble in water.
Chemical Name: 2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one
monohydrochloride
Structural Formula:








Molecular Formula: C19H22ClN5O•HCl
Molecular Weight: 408.32
Oleptro tablets containing 150 mg or 300 mg of trazodone hydrochloride are
designed to release their drug content over a 24-hour period and are intended
for once-a-day dosing.
Inactive Ingredients:
Hydroxypropyl distarch phosphate (Contramid®)
Hypromellose
Sodium stearyl fumarate
Colloidal silicon dioxide
Iron Oxide Yellow
Iron Oxide Red
Talc
Polyethylene Glycol 3350
Titanium Dioxide
Polyvinyl Alcohol
Black ink (food grade)
Last reviewed on RxList: 2/25/2010




Oleptro Drug Description
OLEPTRO
(trazodone hydrochloride) Extended-Release Tablets

WARNING
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of Oleptro or any other antidepressant in a child,
adolescent, or young adult must balance this risk with the clinical need. Short-term
studies did not show an increase in the risk of suicidality with antidepressants
compared to placebo in adults beyond age 24; there was a reduction in risk with
antidepressants compared to placebo in adults aged 65 and older. Depression
and certain other psychiatric disorders are themselves associated with increases
in the risk of suicide. Patients of all ages who are started on antidepressant
therapy should be monitored appropriately and observed closely for clinical
worsening, suicidality, or unusual changes in behavior. Families and caregivers
should be advised of the need for close observation and communication with the
prescriber. Oleptro is not approved for use in pediatric patients [see WARNINGS
AND PRECAUTIONS and PATIENT
INFORMATION].

DRUG DESCRIPTION
Oleptro (trazodone hydrochloride) is a triazolopyridine. It is a white, odorless
crystalline powder which is freely soluble in water.
Chemical Name: 2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one
monohydrochloride
Structural Formula:








Molecular Formula: C19H22ClN5O•HCl
Molecular Weight: 408.32
Oleptro tablets containing 150 mg or 300 mg of trazodone hydrochloride are
designed to release their drug content over a 24-hour period and are intended
for once-a-day dosing.
Inactive Ingredients:
Hydroxypropyl distarch phosphate (Contramid®)
Hypromellose
Sodium stearyl fumarate
Colloidal silicon dioxide
Iron Oxide Yellow
Iron Oxide Red
Talc
Polyethylene Glycol 3350
Titanium Dioxide
Polyvinyl Alcohol
Black ink (food grade)
Last reviewed on RxList: 2/25/2010




Oleptro Drug Description
OLEPTRO
(trazodone hydrochloride) Extended-Release Tablets

WARNING
SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of Oleptro or any other antidepressant in a child,
adolescent, or young adult must balance this risk with the clinical need. Short-term
studies did not show an increase in the risk of suicidality with antidepressants
compared to placebo in adults beyond age 24; there was a reduction in risk with
antidepressants compared to placebo in adults aged 65 and older. Depression
and certain other psychiatric disorders are themselves associated with increases
in the risk of suicide. Patients of all ages who are started on antidepressant
therapy should be monitored appropriately and observed closely for clinical
worsening, suicidality, or unusual changes in behavior. Families and caregivers
should be advised of the need for close observation and communication with the
prescriber. Oleptro is not approved for use in pediatric patients [see WARNINGS
AND PRECAUTIONS and PATIENT
INFORMATION].

DRUG DESCRIPTION
Oleptro (trazodone hydrochloride) is a triazolopyridine. It is a white, odorless
crystalline powder which is freely soluble in water.
Chemical Name: 2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one
monohydrochloride
Structural Formula:








Molecular Formula: C19H22ClN5O•HCl
Molecular Weight: 408.32
Oleptro tablets containing 150 mg or 300 mg of trazodone hydrochloride are
designed to release their drug content over a 24-hour period and are intended
for once-a-day dosing.
Inactive Ingredients:
Hydroxypropyl distarch phosphate (Contramid®)
Hypromellose
Sodium stearyl fumarate
Colloidal silicon dioxide
Iron Oxide Yellow
Iron Oxide Red
Talc
Polyethylene Glycol 3350
Titanium Dioxide
Polyvinyl Alcohol
Black ink (food grade)
Last reviewed on RxList: 2/25/2010





Other reviews about Oleptro on wordpress

Top Day Trader Alerts (APKT, ANX, ALVR, AUXL, CTRP, SOLR, HDIX, DDSS, MYGN, NETL, NWS, VRSN, WU)
  by 247wallst
These are this morning's top day trader and active trader alerts with a brief explanation of the news behind the moves: Acme Packet, Inc. (NASDAQ: APKT) up 14% at […]


Labopharm to partner With Quintiles?
  by silico
The Wall Street Journal speculates that Labopharm could collaborate with Quintiles to market its recently appoved OLEPTRO drug in the US.


Monday Biotech Deal Review: May 3, 2010
  by Jeremy G
I guess the excitement of BIO was driving deals this week. To the delight of the economic development folks, government was in on the action -- Ontario announced a […]


Monday Biotech Deal Review: May 24, 2010
  by Jeremy G
The lead up to the long weekend here in Canada (Victoria Day, in case you're wondering where we all went) saw only one new financing and two new […]



Other reviews about Oleptro on web:

Important Safety Information About Treatment with OLEPTRO™ For more complete information about the use of OLEPTRO™, please see the full Prescribing Information and Medication ... Oleptro - Now Approved!


Oleptro (trazodone hydrochloride) is used to treat major depressive disorder. Includes Oleptro side effects, interactions and indications. Oleptro Information from Drugs.com


Accurate, FDA approved Oleptro information for healthcare professionals and patients - brought to you by Drugs.com. Oleptro Official FDA information, side effects and uses.


Labopharm Receives FDA Approval For OLEPTRO(TM). - Second U.S. FDA Product Approval in Just Over a Year For Labopharm's CONTRAMID(R) Controlled Release Technology -. Labopharm Receives FDA Approval For OLEPTRO(TM)


Learn about the prescription medication Oleptro (Trazodone Hydrochloride Extended-Release Tablets), drug uses, dosage, side effects, drug interactions, warnings, reviews and ... Oleptro (Trazodone Hydrochloride Extended-Release Tablets) Drug ...


Oleptro is approved to treat major depressive disorder (MDD). MDD is a common disease characterized by a number of social and somatic symptoms.Oleptro (trazadone) side effects ... Oleptro. Oleptro US FDA


Oleptro, Desyrel, Desirel, Beneficat, Deprax, Molipaxin, Thombran, Trazorel, Trialodine, Trittico Oleptro Side Effects, Uses, & Interactions


Oleptro Information, Learn About Oleptro, Oleptro Forums, How to Take Oleptro, Oleptro Side Effects, Oleptro Interactions, Discussion Threads, Medication Warnings, Oleptro Overdose ... Oleptro - The People's Medicine Community


Oleptro is a long-acting medication prescribed for the treatment of depression. This section of the eMedTV Web site provides a complete overview of this antidepressant, including ... Oleptro


Oleptro is a pharmaceutical brand name of Trazodone hydrochloride, a triazolopyridine antidepressant drug, manufactured and marketed by Labopharm Europe Limited, Dublin, Ireland. Oleptro - Wikipedia, the free encyclopedia





Featured Reviews

Reviews Lamisil

Lamisil Drug Description LAMISIL® (terbinafine hydrochloride) Tablets DRUG DESCRIPTION What are the possible side effects of terbinafine (Lamisil)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Calcitriol Ointment

Vectical Ointment Drug Description VECTICAL (calcitriol) Ointment 3 mcg/g For topical use only DRUG DESCRIPTION What are the possible side effects of calcitriol topical (Vectical)? Get emergency medical help if you have any...
Read More  |  Review This
Reviews Meropenem

Merrem I.V. Drug Description MERREM® I.V. (meropenem) for Injection FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of MERREM® I.V. (meropenem for injection) and...
Read More  |  Review This
Reviews Clarinex

Clarinex Drug Description CLARINEX® (desloratadine) Tablets, Syrup, Reditabs® Tablets DRUG DESCRIPTION What are the possible side effects of desloratadine (Clarinex, Clarinex Reditabs)? Get emergency medical help if you...
Read More  |  Review This
Reviews Cartia XT

Cartia XT Drug Description CARTIA XT™ (diltiazem hydrochloride) Extended-Release Capsules USP (Once-A-Day Dosage) DRUG DESCRIPTION What are the possible side effects of diltiazem? Get emergency medical help if you have...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....